| StreetAuthority

Bookmark this page | this site

Hi, Guest

Subscribers only

More news

[$$] Pharma Looks Ready to Turn Defense Into Offense – February 9, 2012 - 05:53 PM
Speedy Review for Roche Drug – February 9, 2012 - 03:25 PM
How the Wheels Came off GlaxoSmithKline's Bus – February 9, 2012 - 09:58 AM
5 Defensive Stocks For A Highly Volatile Market – February 9, 2012 - 09:39 AM
Facebook Alternatives: Less Hype, More Hope – February 8, 2012 - 11:14 PM
GlaxoSmithKline: A Good Mix Of Income And Opportunity – February 8, 2012 - 05:48 PM
U.K. Mega Caps Earnings And Dividend Update – February 8, 2012 - 05:22 PM
Anticipation – February 8, 2012 - 05:00 PM
[$$] Buyers Drive IPO Price Cuts, Bringing Good Debuts – February 8, 2012 - 03:51 PM
Eurodebt Woes for the European Drug Sector – February 8, 2012 - 03:05 PM
[$$] Sanofi Warns on 2012 Earnings – February 8, 2012 - 01:52 PM
Amgen Upped to Outperform – February 8, 2012 - 12:45 PM

Market Summary

Free Newsletters

Today's Hot Topics

Quick Links

Customer Service

About StreetAuthority

Legal

StreetAuthority.com

Newsletters

Premium

Free

Articles RSS Feed

DISCLAIMER: StreetAuthority, LLC is a publisher of financial news and opinions and NOT a securities broker/dealer or an investment advisor. You are responsible for your own investment decisions. All information contained in our newsletters or on our website(s) should be independently verified with the companies mentioned, and readers should always conduct their own research and due diligence and consider obtaining professional advice before making any investment decision. As a condition to accessing StreetAuthority materials and websites, you agree to our Terms and Conditions of Use, available here, including without limitation all disclaimers of warranties and limitations on liability contained therein. Owners, employees and writers may hold positions in the securities that are discussed in our newsletters or on our website.

Copyright 2001 - 2012. StreetAuthority, LLC All Rights Reserved.

Created by: